We propose the category of remanent surplus value: the value transferredto each copy of a commodity by accumulated scientific knowledge --- socialized in itsorigin, unwearable in its nature, unpaid in the present. We define remanent laboras the past labor crystallized in a support that does not wear out, and which continuesto act without being consumed by its exercise. We show that this category is asecond mode of labor-power in Marx's sense: an aptitude to produce, but an aptitudeimpermeable to use, whose cost of reproduction in the present is zero. We deduce adouble accounting: value (an extensive magnitude) divides with the copies andtends toward zero; remanence (an intensive magnitude) remains whole in each copy andproduces remanent surplus value. We define two production regimes by the structureof their production cycle (one-cycle vs.\ two-cycle regimes), propose two measurabletracers (the labor--EBIT correlation and the operating margin), and evaluate theframework on a panel of listed firms, 2015--2024, estimated by hierarchical maximumlikelihood. We discuss the implications for the ``techno-feudalism'' debate: thesuper-profits of tech and pharma are proposed to be read not as rents on vassal subjects,but as the realization, copy after copy, of remanent surplus value.
No takes yet. Share an insight, caveat, or question.
Lahoussine Laanait (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: